Condition: Lupus Erythematosus, Systemic · Sponsor: AstraZeneca
This is an observational, multicenter, prospective study on patients with systemic lupus erythematosus treated with anifrolumab in Italy aimed at evaluating the achievement of LLDAS5
This description comes directly from the study's public registry record.
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
| Azienda Ospedaliero-Universitaria di Cagliari Presidio di Monserrato | Monserrato, CA, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria di Ferrara Arcispedale Sant'Anna | Cona, Ferrara, Italy | Recruiting |
| IRCCS Casa Sollievo della Sofferenza | San Giovanni Rotondo, Foggia, Italy | Recruiting |
| IRCCS Humanitas Research Hospital | Rozzano, Milano, Italy | Recruiting |
| AOU Ospedali Riuniti di Ancona - Presidio Torrette | Ancona, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria Policlinico di Bari | Bari, Italy | Withdrawn |
| ASST Spedali Civili di Brescia | Brescia, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria Careggi | Florence, Italy | Recruiting |
| Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | Milan, Italy | Recruiting |
| IRCCS Ospedale San Raffaele | Milan, Italy | Not Yet Recruiting |
| Policlinico di Modena - AOU di Modena | Modena, Italy | Not Yet Recruiting |
| Azienda Ospedaliera Universitaria "Luigi Vanvitelli" | Naples, Italy | Not Yet Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07330245